[SYRS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -3.42%
YoY- 2.43%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 375 370 0 0 0 1,101 317 11.88%
PBT -14,047 -14,463 -15,302 -13,825 -13,368 -11,515 -10,965 18.00%
Tax 0 0 -390 0 0 0 0 -
NP -14,047 -14,463 -15,302 -13,825 -13,368 -11,515 -10,965 18.00%
Tax Rate - - - - - - - -
Total Cost 14,422 14,833 15,302 13,825 13,368 12,616 11,282 17.83%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -3,745.87 -3,908.92 0.00 0.00 0.00 -1,045.87 -3,458.99 5.47%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -4.27 -4.77 -5.81 -5.26 -5.23 -4.92 -4.69 -6.07%
EPS Diluted -4.27 -4.77 -5.81 -5.26 -5.23 -4.92 -4.69 -6.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.